HGH Benefits Somatropin Deficiency Syndrome

Somatropin Deficiency Syndrome refers to those individuals who have low levels of growth hormone. Since the measurement of (hGH) human growth hormone is difficult, the accepted method is to measure Somatomedin-C,or by it's newer name, Insulin Growth Factor-1 (IGF-1). Corning Laboratories in San Diego, California has established their normal range of IGF-1 to be 90-360 ug/ml. Based on the work of leading researchers, Somatropin Deficiency Syndrome is defined as a value below 160 ug/ml.

HGH Benefits Human Growth Hormone

Perhaps the largest human growth hormone study on the effects of human growth hormone on humans has taken place at the Palm Springs Life Extension Institute under the direction of Dr. Edmund Chein, director of the institute, and his associate Dr. Leon Terry, a neuroendocrinologist from the Department of Neurology at the Medical College of Wisconsin.

Dr.Chein follows a protocol that involves restoring (Hormone levels for (hgh) Human Growth Hormone patients who are deficient (IGF-1 less than 350 mg/ml) with low dose, high frequency growth hormone injections. Dr. Chein, by combining growth hormone injections with other hormones that are shown to be low, has developed an growth hormone program that he claims has been 100% effective for all of his patients. He guarantees that his patients will experience exceptional hgh benefits such as increased bone density, decreased body fat, increased lean muscle mass, higher energy levels, increased memory, and an overall better of quality of life from hgh injections. These human growth hormone treatments may continue until the patient attains the hgh benefits a twenty year old.

HGH Benefits from Anti-Aging Therapy Assessments  

Recently, Dr.Terry collected the data of patients who have been treated at the Life Extension Institute with (hgh) human growth hormone and has written up the amazing results that you receive from taking (hgh) human growth hormone. The following assessment figures were derived from randomly selected, self-assessment questionnaires completed by 202 patients during the term of their therapy programs between the years of 1994 and 1996. In general, improvements were reported to occur within one to three months from the day therapy begins with a tendency of the treatment to continue improving over six months.